That is the assessment of OMT member Andreas Voss, professor of infectious diseases at Radboudumc in Nijmegen. ,,Small but not absent”, he adds for the sake of completeness.
–
To be able to say something with more certainty about this, more information is needed about omikron. “We’ll know more in a week.” In addition, boosting faster will certainly help to prevent many people from ending up in hospital because of omikron, he thinks.
–
